Appeal No. 1999-1417
Application 08/268,730
Representative Claims
Claims 74 and 76, which are illustrative of the subject matter on appeal, read as
follows:
74. A pharmaceutical composition containing, as active ingredient, an N-acyl-
lysoganglioside wherein the acyl group is derived from an aliphatic acid having from 2 to
12 carbon atoms, substituted with at least one polar group selected from the group
consisting of
chlorine and fluorine and etherified hydroxy groups
or esters or amides of the sialic carboxy groups of said N-acyl-lysogangliosides,
inner esters of said N-acyl-lysogangliosides, peracylated derivatives of said N-acyl-
lysogangliosides, metal salts or organic base salts of said N-acyl-lysogangliosides having
acid groups, acid addition salts of said N-acyl-lysogangliosides and mixtures of said N-
acyl-lysogangliosides, together with a pharmaceutically acceptable excipient.
76. A method of treating disorders related to excitatory amino acid-induced
neurotoxicity wherein an N-acyl-lysoganglioside wherein the acyl group is derived from an
aliphatic acid having from 2 to 12 carbon atoms, substituted with at least one polar group
selected from the group consisting of
chlorine and fluorine and etherified hydroxy groups
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007